Hospira Logo (Labetalol 01)
Labetalol Hydrochloride Injection, Solution
Product Images NDC 0409-2339
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 0409-2339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula Labetalol HCl (Labetalol 02)
Hospira Logo (Labetalol 03)
Principal Display Panel (4 mL Cartridge Label)
This is a single-dose sterile cartridge containing Labetalol Hydrochloride injection for intravenous use. It is a 4 mL Carpuject NDC for RX only and has a Luer Lock. The concentration of Labetalol Hydrochloride in the cartridge is 5mg/mL, providing a total of 20mg. The distributed is Hospira, Inc. in the USA.*
Principal Display Panel (4 mL Cartridge Carton)
This is a description of a medication called Labetalol Hydrochloride. It is an injection available in a 5mg/mL concentration in 1mL and 4mL Carpuject sterile cartridge units with a Luer Lock. The cartridge unit is only to be used with Carpuject Handlers, and the needle is not included. This medication also contains anhydrous dextrose, edetate disodium, citric acid, and various other ingredients to adjust pH and act as preservatives. The package insert should be consulted for adult dosages and administration, and the medication should be stored within a certain range of temperatures. The manufacturer is Hospira, Inc., and the product is made in Italy.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
